$700M BNB Move Fails to Save Windtree From Nasdaq Delisting
Windtree Therapeutics, a biotech firm that recently announced a $700 million BNB treasury strategy, has been delisted from Nasdaq for…
Tag: Windtree
Windtree Secures $520 Million to Expand BNB Treasury Strategy
Windtree Therapeutics has announced up to $520 million in new funding, with 99% of proceeds earmarked for BNB acquisitions, signaling…
BNB Rebounds to $780 After $520M Windtree Buy Commitment, Shows Signs of Stabilizing
BNB rose around 0.6% in the last 24 hours, shaking off a recent drop to now trade close to $780.…
Bullish on BNB? Windtree Therapeutics unveils $520m funding plan
Nasdaq-listed Windtree Therapeutics unveils new funding plans to generate $520 million. Most of the funds will be used to accelerate…
Nasdaq-listed Windtree to buy $60m BNB in crypto strategy push
Windtree Therapeutics, a Nasdaq-listed company, has announced plans to buy $60 million BNB as part of its push for a…